Analog Devices Appoints Andrea F. Wainer to its Board of Directors
Analog Devices (NASDAQ: ADI) has appointed Andrea F. Wainer to its Board of Directors as an independent director. Wainer will also serve on the Board's Nominating and Corporate Governance Committee. She currently serves as Executive Vice President of Rapid and Molecular Diagnostics at Abbott Laboratories, where she leads three businesses focused on molecular diagnostics, rapid point-of-care diagnostics, and hand-held point-of-care devices.
Wainer brings extensive healthcare sector experience from leadership positions at Abbott, Pfizer, and Astellas Pharma. Her previous roles include President of Abbott Molecular Diagnostics, President of Abbott Animal Health, and Divisional Vice President/General Manager of Abbott Renal Care. She holds a Bachelor's Degree in Accounting from Washington University and an MBA from Northwestern University.
Analog Devices (NASDAQ: ADI) ha nominato Andrea F. Wainer nel suo Consiglio di Amministrazione come direttore indipendente. Wainer farà anche parte del Comitato per le Nomine e la Governance Aziendale del Consiglio. Attualmente ricopre il ruolo di Vice Presidente Esecutivo per i Diagnostici Rapidi e Molecolari presso Abbott Laboratories, dove guida tre settori focalizzati sui diagnosi molecolari, diagnosi rapide in loco e dispositivi portatili per diagnosi in loco.
Wainer porta con sé una vasta esperienza nel settore sanitario, derivante da ruoli dirigenziali in Abbott, Pfizer e Astellas Pharma. Le sue esperienze precedenti includono Presidente dei Diagnostici Molecolari di Abbott, Presidente della Salute Animale di Abbott e Vice Presidente Divisionale/Direttore Generale di Abbott Renal Care. Ha conseguito una Laurea in Contabilità presso la Washington University e un MBA presso la Northwestern University.
Analog Devices (NASDAQ: ADI) ha nombrado a Andrea F. Wainer en su Junta Directiva como directora independiente. Wainer también formará parte del Comité de Nominaciones y Gobernanza Corporativa de la Junta. Actualmente, se desempeña como Vicepresidenta Ejecutiva de Diagnósticos Rápidos y Moleculares en Abbott Laboratories, donde lidera tres negocios enfocados en diagnósticos moleculares, diagnósticos rápidos en el punto de atención y dispositivos portátiles para cuidados en el punto de atención.
Wainer aporta una amplia experiencia en el sector salud de posiciones de liderazgo en Abbott, Pfizer y Astellas Pharma. Sus roles anteriores incluyen Presidenta de Diagnósticos Moleculares de Abbott, Presidenta de Salud Animal de Abbott y Vicepresidenta Divisional/Gerente General de Abbott Renal Care. Posee un título de Licenciatura en Contabilidad de la Universidad de Washington y un MBA de la Universidad Northwestern.
아날로그 디바이스(리스트: ADI)는 안드레아 F. 웨이너를 독립 이사로 이사회에 임명했습니다. 웨이너는 이사회 내 인사 및 기업 거버넌스 위원회에서도 활동할 예정입니다. 현재 그녀는 Abbott Laboratories의 신속 및 분자 진단 부문 부사장으로 재직하며, 분자 진단, 신속한 진단, 휴대용 진단 장치에 중점을 둔 세 개의 사업부를 이끌고 있습니다.
웨이너는 Abbott, Pfizer 및 Astellas Pharma에서의 리더십 경험을 바탕으로 헬스케어 분야에서 폭넓은 경험을 쌓아왔습니다. 그녀의 이전 역할에는 Abbott Molecular Diagnostics 사장, Abbott Animal Health 사장 및 Abbott Renal Care의 부사장/총괄 관리자가 포함됩니다. 그녀는 워싱턴 대학교에서 회계학 학사 학위를 받았고, 노스웨스턴 대학교에서 MBA를 취득했습니다.
Analog Devices (NASDAQ: ADI) a nommé Andrea F. Wainer à son Conseil d'administration en tant que directrice indépendante. Wainer siégera également au Comité des nominations et de la gouvernance d'entreprise du Conseil. Actuellement, elle est Vice-présidente exécutive des diagnostics rapides et moléculaires chez Abbott Laboratories, où elle dirige trois activités axées sur le diagnostic moléculaire, le diagnostic rapide au point de soins et les dispositifs portables au point de soins.
Wainer apporte une vaste expérience du secteur de la santé grâce à des postes de direction chez Abbott, Pfizer et Astellas Pharma. Ses précédents rôles incluent présidente d'Abbott Molecular Diagnostics, présidente d'Abbott Animal Health et vice-présidente divisionnelle / directrice générale d'Abbott Renal Care. Elle est titulaire d'une licence en comptabilité de l'Université de Washington et d'un MBA de l'Université Northwestern.
Analog Devices (NASDAQ: ADI) hat Andrea F. Wainer in seinen Aufsichtsrat als unabhängige Direktorin berufen. Wainer wird außerdem im Nominierungs- und Corporate Governance-Ausschuss des Aufsichtsrats tätig sein. Derzeit ist sie als Executive Vice President für schnelle und molekulare Diagnostik bei Abbott Laboratories tätig, wo sie drei Geschäftsbereiche leitet, die sich auf molekulare Diagnostik, schnelle Diagnostik am Point-of-Care und tragbare Geräte für die Diagnostik am Point-of-Care konzentrieren.
Wainer bringt umfangreiche Erfahrung im Gesundheitssektor aus Führungspositionen bei Abbott, Pfizer und Astellas Pharma mit. Zu ihren bisherigen Rollen gehören Präsidentin von Abbott Molecular Diagnostics, Präsidentin von Abbott Animal Health und Divisional Vice President/General Manager von Abbott Renal Care. Sie hat einen Bachelor-Abschluss in Buchhaltung von der Washington University und einen MBA von der Northwestern University.
- Addition of healthcare sector expertise to the board through appointment of experienced executive
- Strategic enhancement of leadership team with expertise in diagnostics and medical technology
- None.
"We are delighted to welcome Andrea to the ADI Board, as her deep experience and leadership in the healthcare sector will provide ADI with an important source of wisdom and knowledge as we navigate the rich opportunity landscape ahead of us," said Vincent Roche, ADI's CEO and Chair.
Wainer is a highly versatile, results-oriented leader with expertise leading innovative businesses at Abbott Laboratories (Abbott), Pfizer and Astellas Pharma. Since 2019, she has served as Executive Vice President, Rapid and Molecular Diagnostics at Abbott. In this role, she leads three businesses – one focused on molecular diagnostics and the analysis of DNA and RNA at the molecular level, the second a provider of rapid point-of-care diagnostics, and the third delivers a leading hand-held point-of-care device.
Previous roles held include President, Abbott Molecular Diagnostics; President, Abbott Animal Health; and Divisional Vice President/General Manager, Abbott Renal Care.
Wainer also serves as a member of the Board of Trustees of the Goodman Theatre.
She earned a Bachelor's Degree in Accounting from the John M. Olin School of Business,
About Analog Devices, Inc.
Analog Devices, Inc. (NASDAQ: ADI) is a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. ADI combines analog, digital, and software technologies into solutions that help drive advancements in digitized factories, mobility, and digital healthcare, combat climate change, and reliably connect humans and the world. With revenue of more than
All trademarks and registered trademarks are the property of their respective owners.
CONTACT:
Ferda Millan
Global PR and External Communications
Analog Devices
CorpComm@analog.com
(408) 373-1854
Michael Lucarelli
Vice President, Investor Relations and FP&A
Analog Devices
Investor.Relations@analog.com
(781) 461-3282
View original content to download multimedia:https://www.prnewswire.com/news-releases/analog-devices-appoints-andrea-f-wainer-to-its-board-of-directors-302356855.html
SOURCE Analog Devices, Inc.
FAQ
Who is the new board member appointed to Analog Devices (ADI)?
What committees will Andrea Wainer serve on at ADI?
What is Andrea Wainer's current role outside of ADI?
What is the strategic significance of Andrea Wainer's appointment to ADI?
